Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study

Inclusion Criteria

• •Patients age is18 years or greater;
• •Patients undergoing a first-time ablation procedure for AF;
• •Patients with persistent AF;
• •Persistent AF will be defined as a sustained episode lasting \> 7 days and less than 3 years.
• •Patients with symptomatic AF that is refractory to at least one antiarrhythmic medication;
• •At least one episode of persistent AF must have been documented by ECG, holter, loop recorder, telemetry, trans telephonic monitoring (TTM), or implantable device within last 2 years of enrollment in this investigation;
• •Patients must be able and willing to provide written informed consent to participate in this investigation; and
• •Patients must be willing and able to comply with all peri-ablation and follow-up requirements.